Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Clin Pharmacol Ther. 2018 Jan 17;104(3):575–583. doi: 10.1002/cpt.988

Table 1. Patient demographics.

Parameters N= 87 (%) Median (range)
Age, yrs 9.0 (1.5–25)
Body weight, kg 23.2 (11.4–55.0)
BSA, m2 0.93 (0.48–1.56)
Liver size, cm 4.0 (0–14)
Ferritin, ng 3047 (536–13084)
Sex
Male N = 55 (63%)
Female N = 32 (37%)
Splenectomy
Yes N = 10 (11.5%)
No N = 77 (88.5%)
Liver fibrosis
Yes N = 81 (93%)
No N = 06 (7%)
Risk
Class III HR N = 42 (48.3%)
Class III LR N = 32 (36.8%)
Class II N = 13 (14.9%)
Donor source
MSD N = 67 (77%)
MRD N = 11 (13%)
MUD N = 9 (10%)

Class III HR, class III high risk; LR, low risk; MSD, matched sibling donor; MRD, matched related donor; MUD, matched unrelated donor.